Safety, operating, and evidence infrastructure
Make advanced therapies accessible to more patients
Current Health helps health systems, cancer centers, and community oncology practices deliver CAR-T, bispecifics, and other advanced therapies safely outside the hospital, and helps pharma and biotech companies advance the development of, and commercial access to, these therapies. We pair toxicity detection matched to each therapy with a 24/7 team of experienced nurses, familiar with CRS and ICANS, who work under each program's protocols.
60
peer-reviewed papers and abstracts
1,500+
advanced therapy episodes
$1B+
therapy spend shifted to home
13+
advanced therapy assets supported
Trusted by leading cancer centers and therapy developers
What we do
The safety, operating, and evidence infrastructure to scale advanced therapies
Across CAR-T, bispecifics, TIL therapy, monoclonal antibodies, and other advanced therapies, we support patients at home through the highest-risk days. We take on the clinical coordination, logistics, and program launch work that outpatient care, community delivery, and clinical trials depend on, report on program quality, and generate the real-world evidence that supports broader access.
Who we help
Solutions for everyone who brings advanced therapies to patients
Health systems and cancer centers
Free inpatient capacity, grow referral volume, and scale outpatient delivery across sites and therapies.
Community oncology practices
Offer CAR-T and bispecifics locally and keep patients in your practice, without an inpatient unit or overnight team of your own, with a partner hospital as your backstop.
Pharma and biotech companies
Monitor trial participants outside the clinic, expand the network of sites ready to deliver your therapy commercially, and generate trial-grade and real-world evidence.
Our models
Proven models with protocols and SOPs for each therapy
A bispecific step-up dose and an outpatient CAR-T infusion carry different risks. Each model starts from draft clinical pathways and escalation rules built for the therapy, which each program’s clinical leads review and approve. The same 24/7 Clinical Coordination Center stands behind every patient, so programs can start where they are and add therapies as they grow.
Current Health for CAR-T
24/7 clinical support through the highest-risk weeks after infusion. Our multi-signal detection picks up CRS, infection and other complications early. Our nurses triage, run virtual ICE assessments and escalate per your protocol, day or night.
Current Health for Bispecifics
Lightweight support for the days after each step-up dose, and through maintenance. Patients send temperature, blood pressure, oxygen saturation, and symptom check-ins from home, our nurses act on anything that needs attention and run virtual ICE assessments when needed. CRS, ICANS, infections and other complications are escalated per your protocol, day or night.
Both run on the same 24/7 Clinical Coordination Center, where our expert nurses resolve 80% or more of patient issues without escalating to your team. Programs already delivering these therapies can go live in 4–6 weeks, with optional EHR integration.
Our solution
One platform behind every model
Detection keeps patients safe, our clinical team runs the program alongside yours, and reporting and evidence show what it achieves, whatever the therapy or setting.
Toxicity detection
Recognize CRS, ICANS, and other adverse events early, with monitoring matched to each therapy’s risk profile.
Clinical coordination
Nurses, drawn from ED and ICU, who assess, treat under your standing orders, escalate, and coordinate the next step around the clock, under your protocols, resolving 80% or more of patient issues without escalating to your team.
Trial and real-world evidence
Trial data delivered to your EDC with 21 CFR Part 11 audit trails, and consented, deidentified data from commercial programs, to support regulatory, payer, and site-of-care decisions.
Protocols and SOPs
Ready-to-go protocols, SOPs, and clinical pathways for each therapy, so your team can launch and scale without writing them from scratch.
Clinical Coordination Center
The clinical team that makes outpatient delivery possible
Our in-house nurses have supported more advanced therapy patients than any other virtual care team. When a patient needs care, they assess, resolve what your protocol allows, escalate the rest, and coordinate the next step, including getting the patient to the hospital your protocol designates and calling ahead to the ED to support safe and efficient handoffs, so the receiving team knows who is coming and why.
24/7/365
always-on coverage, nights, weekends, and holidays included
50
states where our nurses are licensed
01
Assess
Validate signals and symptoms with the patient and caregiver, including a virtual ICE assessment where needed.
02
Initiate treatment
Where your protocol and a standing order allow, our nurses start protocolized treatment, so not every event needs escalation.
03
Escalate
Reach your on-call team or hospital partner, per your protocol.
04
Coordinate transfer
Route the patient to the right hospital or treatment center, arrange transport, and call ahead.
05
Document
Record every interaction in our dashboard, with EHR integration available.
Real-world results
Outpatient and community advanced therapy delivery, tested and proven at scale
Sarah Cannon Cancer Network
The largest multisite outpatient CAR-T program
90%
of CAR-T moved outpatient across four Sarah Cannon sites
UCSF Health
Building outpatient confidence
85%
of patient issues managed without provider escalation
Memorial Sloan Kettering
Outpatient step-up dosing for bispecifics
89%
of patients who began step-up dosing outpatient reached full dose
Mount Sinai
Earlier toxicity detection
7 hrs
median earlier recognition of CRS than standard inpatient nursing care
“Expanding access to CAR-T therapy requires reimagining how and where care is delivered. Partnering with Current Health has allowed us to safely transition CAR-T to an outpatient setting, supporting patients beyond the hospital walls, without compromising safety, quality of care, or clinical oversight.”
Navneet Majhail, MD, FASTCT
Physician-in-Chief, Blood Cancers, Sarah Cannon Cancer Network
Ready to bring advanced therapies closer to your patients?
Health systems, community practices, and pharma and biotech companies all start somewhere different. We’ll show you where to begin.